Point Transformer with Federated Learning for Predicting Breast Cancer HER2 Status from Hematoxylin and Eosin-Stained Whole Slide Images

被引:0
|
作者
Li, Bao [1 ,2 ]
Liu, Zhenyu [2 ]
Shao, Lizhi [2 ]
Qiu, Bensheng [1 ]
Bu, Hong [3 ]
Tian, Jie [1 ,2 ,4 ]
机构
[1] Univ Sci & Technol China, Ctr Biomed Imaging, Hefei, Peoples R China
[2] Chinese Acad Sci, Beijing Key Lab Mol Imaging, Inst Automat, CAS Key Lab Mol Imaging, Beijing, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China
[4] Beihang Univ, Sch Engn Med, Key Lab Big Data Based Precis Med, Minist Ind & Informat Technol, Beijing, Peoples R China
来源
THIRTY-EIGHTH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOL 38 NO 4 | 2024年
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
D O I
暂无
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Directly predicting human epidermal growth factor receptor 2 (HER2) status from widely available hematoxylin and eosin (HE)-stained whole slide images (WSIs) can reduce technical costs and expedite treatment selection. Accurately predicting HER2 requires large collections of multi-site WSIs. Federated learning enables collaborative training of these WSIs without gigabyte-size WSIs transportation and data privacy concerns. However, federated learning encounters challenges in addressing label imbalance in multi-site WSIs from the real world. Moreover, existing WSI classification methods cannot simultaneously exploit local context information and long-range dependencies in the site-end feature representation of federated learning. To address these issues, we present a point transformer with federated learning for multi-site HER2 status prediction from HE-stained WSIs. Our approach incorporates two novel designs. We propose a dynamic label distribution strategy and an auxiliary classifier, which helps to establish a well-initialized model and mitigate label distribution variations across sites. Additionally, we propose a farthest cosine sampling based on cosine distance. It can sample the most distinctive features and capture the long-range dependencies. Extensive experiments and analysis show that our method achieves state-of-the-art performance at four sites with a total of 2687 WSIs. Furthermore, we demonstrate that our model can generalize to two unseen sites with 229 WSIs. Code is available at: https://github.com/boyden/PointTransformerFL
引用
收藏
页码:3000 / 3008
页数:9
相关论文
共 50 条
  • [11] An interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer from hematoxylin and eosin-stained pathological images
    Li, Yi
    Xiong, Xiaomin
    Liu, Xiaohua
    Wu, Yihan
    Li, Xiaoju
    Liu, Bo
    Lin, Bo
    Li, Yu
    Xu, Bo
    PEERJ, 2024, 12
  • [12] Machine learning prediction of HER2-low expression in breast cancers based on hematoxylin–eosin-stained slides
    Jun Du
    Jun Shi
    Dongdong Sun
    Yifei Wang
    Guanfeng Liu
    Jingru Chen
    Wei Wang
    Wenchao Zhou
    Yushan Zheng
    Haibo Wu
    Breast Cancer Research, 27 (1)
  • [13] Deep learning-based approach to predict multiple genetic mutations in colorectal and lung cancer tissues using hematoxylin and eosin-stained whole-slide images
    Konishi, Teppei
    Grynkiewicz, Mateusz
    Saito, Keita
    Kobayashi, Takuma
    Goto, Akiteru
    Umakoshi, Michinobu
    Iwata, Takashi
    Nishio, Hiroshi
    Katoh, Yuki
    Fujita, Tomonobu
    Matsui, Tomoya
    Sugawara, Masaki
    Sano, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [14] Evaluation of HER2 scoring in breast carcinoma-stained whole slide images
    Bossard, C.
    Salhi, Y.
    Florian, T.
    Poulet, B.
    Cormier, B.
    Salhi, S.
    Guinaudeau, E.
    Lambros, L.
    Chokri, I.
    Jossic, F.
    Chetritt, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S387 - S387
  • [15] Clinical utility of receptor status prediction in breast cancer and misdiagnosis identification using deep learning on hematoxylin and eosin-stained slides
    Shamai, Gil
    Schley, Ran
    Cretu, Alexandra
    Neoran, Tal
    Sabo, Edmond
    Binenbaum, Yoav
    Cohen, Shachar
    Goldman, Tal
    Polonia, Antonio
    Drumea, Keren
    Stoliar, Karin
    Kimmel, Ron
    COMMUNICATIONS MEDICINE, 2024, 4 (01):
  • [16] Strategies for Enhancing the Multi-Stage Classification Performances of HER2 Breast Cancer from Hematoxylin and Eosin Images
    Shovon, Md. Sakib Hossain
    Islam, Md. Jahidul
    Nabil, Mohammed Nawshar Ali Khan
    Molla, Md. Mohimen
    Jony, Akinul Islam
    Mridha, M. F.
    DIAGNOSTICS, 2022, 12 (11)
  • [17] Leveraging IHC Staining to Prompt HER2 Status Prediction from HE-Stained Histopathology Whole Slide Images
    Wang, Yuping
    Sun, Dongdong
    Shi, Jun
    Wang, Wei
    Jiang, Zhiguo
    Wu, Haibo
    Zheng, Yushan
    MACHINE LEARNING IN MEDICAL IMAGING, PT I, MLMI 2024, 2025, 15241 : 133 - 142
  • [18] Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+breast cancer
    Farahmand, Saman
    Fernandez, Aileen, I
    Ahmed, Fahad Shabbir
    Rimm, David L.
    Chuang, Jeffrey H.
    Reisenbichler, Emily
    Zarringhalam, Kourosh
    MODERN PATHOLOGY, 2022, 35 (01) : 44 - 51
  • [19] Predicting HER2 Status in Breast Cancer on Ultrasound Images Using Deep Learning Method
    Xu, Zilong
    Yang, Qiwei
    Li, Minghao
    Gu, Jiabing
    Du, Changping
    Chen, Yang
    Li, Baosheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [20] Prediction of Lymph Node Metastasis in T1 Colorectal Cancer Using Artificial Intelligence with Hematoxylin and Eosin-Stained Whole-Slide-Images of Endoscopic and Surgical Resection Specimens
    Song, Joo Hye
    Kim, Eun Ran
    Hong, Yiyu
    Sohn, Insuk
    Ahn, Soomin
    Kim, Seok-Hyung
    Jang, Kee-Taek
    CANCERS, 2024, 16 (10)